BioSpace News Archive

Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and therapeutic platforms, announced that Harry Stylli, Ph.D., CEO, will be participating in several upcoming investor conferences.

Neovasc Inc. announced that it has commenced a proposed underwritten public offering of common shares of the Company.

Hill-Rom Holdings, Inc., will present at the Barclays Global Healthcare Conference on Wednesday, March 13, 2019, in Miami, Florida.

Intersect ENT, Inc. reported financial results for the fourth quarter and full year ended December 31, 2018.

Clementia’s late-stage drug candidate, palovarotene, has rare pediatric disease and breakthrough therapy designations for the treatment of an ultra-rare bone disorder and a path to approval in 2020

A manufacturing agreement was signed in November 2018 with an undisclosed U.S. cell therapy company for the production of cGMP compliant material to support its clinical development programs.

$20 million commitment from the Marcus Foundation positions Jefferson Department of Integrative Medicine and Nutritional Sciences to set global standards in teaching and research

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced it will present 19 abstracts during the 2019 American Academy of Dermatology (AAD) Annual Meeting, March 1-5, in Washington, D.C., including new data from the psoriasis pivotal trials for risankizumab, an investigational interleukin-23 (IL-23) inhibitor.

Tru-D SmartUVC as part of a comprehensive infection reduction program

The launch will mark the release of awareness backpacks, the latest release in their line of products that promote awareness to, and support, common social and societal issues.